AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

The Trump administration is delaying the release of TrumpRx, an online platform that lets people buy prescription drugs ...

Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are ...

Silicon Valley and Wall Street are pouring billions into AI drug discovery in a high-stakes bet to “solve” disease.

Manufacturers are pushing for higher prices overseas, but face political and economic resistance.

Investors expect a surge in deal activity in 2026 as drug makers look to replenish pipelines and capitalize on low interest ...

Add Yahoo as a preferred source to see more of our stories on Google. During a press conference in the Oval Office and surrounded by many of his most senior aides, including HHS Secretary Robert ...

Penn State University has sued several pharmaceutical companies alleging they conspired to inflate the price of insulin and ...

The next major drugmaker interested in what Repertoire has to offer is Eli Lilly, which has thrown down $85 million upfront and floated up to $1.84 billion more in biobucks to collaborate on potential ...

SACRAMENTO, California — California will start selling low-cost insulin in January, becoming the first state in the nation to bypass Big Pharma with its own supply of the expensive diabetes drug and ...

Pharmaceutical companies are accused of abusing the patent system to keep drug prices high. Patent manipulation can delay the availability of cheaper generic alternatives for life-saving medications.